Novoste is out to show that the changing device world still has room, in the right market, for a small single-product company to succeed against larger competitors. by Stephen Levin For someone who ot
by Wendy Diller In the year and a half since Johnson & Johnson received FDA approval for the first coronary stent for prevention of restenosis following balloon angioplasty, the market for the devi